Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

A fresh price-target cut slams the Canadian pot company's shares.

Why Few Investors Were High on Tilray Stock Today

Canopy Growth

2 Marijuana Stocks To Buy This August? The post 2 Marijuana Stocks To Watch First Week Of August appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Watch First Week Of August

Borr Drilling Ltd

Hive Blockchain Technologies Ltd

Kinross Gold

Mullen Automotive

Electrameccanica

Uranium Energy

The iShares Micro Cap ETF (NYSEARCA: IWC ) has declined by 19% year-to-date. However, several penny stocks have witnessed a correction of more than 50% in the last two quarters.

7 Penny Stocks Trading at a Massive Discount Right Now

An analyst downgrades his recommendation to "sell."

Why Tilray Stock Was a Laggard on Friday

HEXO Corp

High Tide

InMed Pharmaceuticals

Lexaria Bioscience

SNDL Inc.

Turning Point Brands

Village Farms International

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

9 Cannabis Stocks on Fire This Week

Benchmark analyst Mike Hickey on Friday downgraded Tilray Brands Inc. TLRY, +11.96% to sell and set a price target of $3 a share after the cannabis company disclosed retail market share losses in Canada to 8.3% in its fiscal fourth quarter, from 10.2% in the third quarter and 12.8% in the second quarter. "We are not convinced 'corporate cannabis' can create compelling products or brands in Canada," Hickey said.

Cannabis company Tilray downgraded to sell by Benchmark

Tilray reported a quarterly loss of more than $450 million, but there was more to the story.

Why Tilray Shares Shot Higher Today

Tilray Brands, Inc. (NASDAQ:TLRY ) Q4 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman & Chief Executive Officer Denise Faltischek - Chief Strategy Officer & Head-International Business Blair MacNeil - President-Canada Carl Merton - Chief Financial Officer Conference Call Participants Victor Ma - Cowen & Co. Andrew Carter - Stifel Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets John Zamparo - CIBC Matt Bottomley - Canaccord Genuity Scott Fortune - Roth Capital Partners Matthew Baker - Cantor Fitzgerald Operator Good morning, everyone and thank you for joining us to discuss Tilray Brands, Incorporated Financial Results for the 2022 Fiscal Fourth Quarter ended May 31, 2022. All lines have been placed on mute to prevent any background noise.

Tilray Brands, Inc. (TLRY) CEO Irwin Simon on Q4 2022 Results - Earnings Call Transcript

Tilray Brands Inc. TLRY, -3.55% shares fell 1.5% in premarket trades Thursday after the cannabis company said it swung to a fourth-quarter loss of $457.8 million, or 90 cents a share, from net income of $33.6 million, or 38 cents a share, in the year-ago quarter. The loss in the latest quarter includes a non-cash impairment of $395 million primarily impacting inventory, goodwill and other intangible assets, related to "changes in market opportunities causing a shift in our strategic priorities" as well as higher rates of borrowing and lower foreign exchange rates.

Tilray swings to loss on impairment charge but revenue beats analyst target

FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency Basis, Net Revenue Increased by 29%

Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results

Tilray Inc. is not expected to turn a profit in its fiscal fourth quarter when it delivers its latest results on Thursday, but analysts have at least held steady on their projected loss for the cannabis company.

Tilray expected to post a quarterly loss with market share losses in Canada and forex headwinds

OrganiGram Holdings Inc.

The Valens Co

Aurora Cannabis

Curaleaf Holdings, Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism.

Don't Rule Out A Bull Market

Its product mix and its inventory situation could pose risks to its share price.

3 Burning Questions Keeping Tilray Investors Up at Night

Despite having some favorable legislation in the pipeline, cannabis stocks continue to struggle. As we look across the board on Tuesday, Aurora Cannabis (NASDAQ: ACB ) and Canopy Growth (NASDAQ: CGC ) are both down about 5.5%.

Cannabis Stocks ACB, HEXO, CGC, TLRY Slump Despite Senate Meeting

Comcast

Southwest Airlines

Merck

Valero Energy

The three major U.S. equity indexes closed mixed on Monday. The Dow Jones Industrial Average added 0.28%, the S&P 500 closed up 0.13%, and the Nasdaq Composite fell 0.43%.

Earnings Previews: Comcast, Merck, Southwest Airlines, Tilray, Valero Energy

Are Canadian Pot Stocks A Buy Before August? The post Best Canadian Marijuana Stocks To Buy Right Now? 3 For Your August List appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy Right Now? 3 For Your August List

Tilray is poised to become a dominant player in the global cannabis market.

Tilray Brands Stock Could Go Parabolic Soon

Clever Leaves Holdings Inc

Greenlane Holdings

Intercure Ltd

Incannex Healthcare Inc

5 Cannabis Stocks You Don't Want to Hit 'Snooze' On

Green Thumb Industries Inc.

Senate Democrats have unveiled the Cannabis Administration and Opportunity Act - which would legalize cannabis in the country. I explain why this is more of a "decriminalization" bill.

Cannabis Legalization In 2022? Green Thumb And Tilray To Benefit

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate. The long awaited and highly anticipated bill, introduced by Senate Majority Leader Chuck Schumer and Senators.

What's Going On With Tilray Stock As Cannabis Legalization Bill Reaches Senate?

Innovative Industrial Properties

Altria

Constellation Brands

Trulieve Cannabis Corp.

The cannabis industry can seem to catch a break. However, if you're risk tolerant, these are the seven best marijuana stocks to buy now.

7 Best Marijuana Stocks to Buy Now

GrowGeneration Corp

Cannabis stocks heating up on Wednesday as investors prepare for a Senate meeting that could introduce a new legalization bill. The post Cannabis Stocks TLRY, CGC, SNDL, GRWG Soar Ahead of Senate Meeting appeared first on InvestorPlace.

Cannabis Stocks TLRY, CGC, SNDL, GRWG Soar Ahead of Senate Meeting

Tilray Brands Inc (NASDAQ: TLRY) shares are trading higher Wednesday in anticipation of a Senate marijuana meeting. The Senate Judiciary Subcommittee on Crime and Terrorism has scheduled a meeting, titled "Decriminalizing Cannabis at the Federal Level: Necessary Steps to Address.

Why Tilray Stock Is Ripping Higher Today

‘WeCare-MedicalCannabis' A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French, and Portuguese ‘WeCare-MedicalCannabis' A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French, and Portuguese

Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis' Across Europe

Although political speculation has spiked up weed stocks, investors ought to recognize the steep challenges of marijuana legalization. The post Why Are Weed Stocks TLRY, CGC, SNDL Up Today?

Why Are Weed Stocks TLRY, CGC, SNDL Up Today?

News for Tilray Brands Stock (TLRY)